Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Minimal Hepatic Encephalopathy
NCT02028429Phase 2Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jul 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in hepatic encephalopathy (HE), sponsored by Post Graduate Institute of Medical Education and Research. Status: unknown.
02
Drugs
sildenafil
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT02028429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028429.